CompletedPhase 3NCT02410772
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centers for Disease Control and Prevention
- Principal Investigator
- Susan Dorman, MDMedical University of South Carolina
- Intervention
- rifapentine(drug)
- Enrollment
- 2516 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2016 – 2021
Study locations (30)
- TBTC Site 82/ ACTG Site 801 USCF AIDS CRS, San Francisco, California, United States
- TBTC Site 24 Columbia Unversity, New York, New York, United States
- TBTC Site 20 UNTHSC (University of North Texas Health Science Center), Fort Worth, Texas, United States
- TBTC Site 62 Baylor College of Medicine & Affiliated Hospitals/VA, Houston, Texas, United States
- TBTC Site 63 San Antonio VA Medical Center (South Texas Group), San Antonio, Texas, United States
- TBTC Site 94/ ACTG Site 12201 Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande do Sul, Brazil
- TBTC Site 91/ ACTG Site 12101 Insituto Nacional de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil
- TBTC Site 36 TB and Chest Service of Hong Kong, China, Hong Kong, China
- TBTC Site 67/ ACTG Site 31730 GHESKIO centers IMIS, Port-au-Prince, Ouest, Haiti
- TBTC Site 45/ ACTG Site 30022: Les Centres Gheskio (INLR), Port-au-Prince, Ouest, Haiti
- TBTC Site 43/ ACTG Site 31441 BJ Medical College, Pune, Maharashtra, India
- TBTC Site 44/ ACTG Site 11701 CART CRS, YRGCARE Medical Centre VHS, Chennai, Tamil Nadu, India
- TBTC Site 02/ ACTG 12501 Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS, Kericho, Kericho County, Kenya
- TBTC Site 39/ ACTG Site 31460 Kisumu CRS, Kisumu, Nyanza Province, Kenya
- TBTC Site 03/ ACTG Site 12601 Moi University Clinical Research Site, Eldoret, Kenya
- +15 more locations on ClinicalTrials.gov
Collaborators
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02410772 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07517445Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGPHASE2NCT07525427Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University